Clinical Research Directory
Browse clinical research sites, groups, and studies.
Effect of Pre-Hospital ARNI Therapy on Short-Term Outcomes in HFrEF
Sponsor: Future University in Egypt
Summary
This study looks at people with heart failure who are admitted to the hospital. The goal of the study is to understand whether taking a heart failure medicine called angiotensin receptor-neprilysin inhibitor (ARNI) before hospital admission affects short-term health outcomes. The study will compare two groups of participants: those who were already taking ARNI before coming to the hospital and those who were not. Information will be collected from medical records during the hospital stay, including heart-related events, kidney-related events, and how long participants stay in the hospital. Some participants will also be followed for a short period after discharge. This study may help improve understanding of outcomes associated with ARNI use in people with heart failure in routine clinical care.
Official title: Evaluating the Impact of Pre-Hospital Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy on Short-Term Clinical Outcomes in Heart Failure Patients With Reduced Ejection Fraction: A Comparative Study
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
140
Start Date
2026-01-10
Completion Date
2026-05-01
Last Updated
2026-01-16
Healthy Volunteers
No
Conditions
Interventions
Prehospital ARNI use
Participants who were using ARNI therapy before hospital admission
No prehospital ARNI use
Participants who were not using ARNI therapy before hospital admission
Locations (1)
Mansoura university Hospital
Al Mansurah, Egypt